Hasabo Elfatih A, Ayyad Fatima A, Alam Eldeen Sara A M, Noureldaim Malaz K, Abdallah Tibyan A, Ahmed Yousra T, Badi Safaa, Khalid Waleed K, Mirghani Hind A, Mohammed Yossra A, Alkhider Lubaba A, Hamad Saada A, Tagelseed Amna M, Elsheikh Ethar H A, Khalid Noon H, Mohammed Samia A, Elmobark Sara O, Ali Ola O, Mohammed Ali Duaa A, Muneer Mohamed S, Awadalla Heitham, Malik Elfatih M
Faculty of Medicine, University of Khartoum, ElQasr Avenue, Khartoum, Khartoum state, 11111, Sudan.
School of Medicine, Ahfad University for Women, Khartoum, Sudan.
Trop Med Health. 2021 Nov 14;49(1):91. doi: 10.1186/s41182-021-00382-4.
Coronavirus disease 2019 (COVID-19) is a pandemic caused by a newly discovered coronavirus. Although clinical manifestations of COVID-19 are mainly pulmonary, some patients have other systemic manifestations. This study aimed to describe the clinical finding and outcomes in Sudanese patients diagnosed with COVID-19.
This retrospective observational study is based on documented files that included patients diagnosed with COVID-19 in seven selected hospitals inside Khartoum. Clinical manifestations, complications and outcomes were extracted from patients' records using an extraction form designed for this study.
Data of 243 patients diagnosed with COVID-19 were analyzed. The mean (SD) age in years was 55.8 (18.4). Out of 116 participants, 27 of them (23.3%) had severe disease, 15 (12.9%) were critically ill. 67.5% of patients were admitted to the hospital within 7 days from onset of symptoms; most of them were admitted to the wards (n = 140,72.5%). Fever (83.2%), cough (70.7%), and shortness of breath (69.2%) were the most commonly recorded clinical manifestations. Sepsis (9.8%) and acidosis (7.8%) were the most frequently reported complications. Death was the final outcome in 21.4% (56/243). Older age and presence of diabetes were found significantly associated with in-hospital death. The laboratory results showed high CRP in 85.6% (119/139), high ferritin in 88.9% (24/27), lactate dehydrogenase had a median of 409.0 (359-760), D-dimer had a median of 3.3 (1.2-16. 6), and 53/105 (50.5%) had low albumin.
Fever was the most mentioned sign among the participants, followed by fatigue. Cough and shortness of breath were the most commonly recorded pulmonary symptoms manifested. Our study showed multiple variables were associated with in-hospital death. The mortality rate was high among severe and critically ill patients diagnosed with COVID-19.
2019冠状病毒病(COVID-19)是由一种新发现的冠状病毒引起的大流行病。虽然COVID-19的临床表现主要为肺部症状,但一些患者还有其他全身症状。本研究旨在描述苏丹COVID-19确诊患者的临床发现和结局。
这项回顾性观察性研究基于喀土穆七家选定医院中确诊为COVID-19患者的记录文件。使用为本研究设计的提取表从患者记录中提取临床表现、并发症和结局。
分析了243例COVID-19确诊患者的数据。平均(标准差)年龄为55.8(18.4)岁。在116名参与者中,27例(23.3%)患有重症,15例(12.9%)为危重症。67.5%的患者在出现症状后7天内入院;其中大多数被收入病房(n = 140,72.5%)。发热(83.2%)、咳嗽(70.7%)和呼吸急促(69.2%)是最常记录的临床表现。脓毒症(9.8%)和酸中毒(7.8%)是最常报告的并发症。死亡是最终结局的患者占21.4%(56/243)。发现年龄较大和患有糖尿病与院内死亡显著相关。实验室结果显示,85.6%(119/139)的患者C反应蛋白升高,88.9%(24/27)的患者铁蛋白升高,乳酸脱氢酶中位数为409.0(359 - 760),D-二聚体中位数为3.3(1.2 - 16.6),53/105(50.5%)的患者白蛋白水平较低。
参与者中提及最多的症状是发热,其次是疲劳。咳嗽和呼吸急促是最常记录的肺部症状。我们的研究表明,多个变量与院内死亡有关。在确诊为COVID-19的重症和危重症患者中,死亡率较高。